E.g., 11/27/2024
E.g., 11/27/2024

‘Bug Squad’ Squashes Barriers to Optimal Antibiotic Rx

04 February, 2016

Long before the term antimicrobial stewardship came into common usage, a small interdisciplinary team at St. Luke’s Magic Valley Medical Center in Twin Falls, Idaho, began employing many of the same antibiotic management practices that have now become prevalent across the country.

bioMérieux acquires Applied Maths and enhances its bioinformatics capabilities with cutting-edge expertise and solutions for the smart use of complex biological data

05 January, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, today announced the acquisition of Applied Maths, a company that develops state-of-the-art software solutions for the biosciences, in particular for databasing, analysis and interpretation of complex biological data.

bioMérieux and Illumina announce the launch of bioMérieux EpiSeq™, a revolutionary Next-Generation Sequencing service for epidemiological monitoring of bacterial infections

15 December, 2015

bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina (Nasdaq: ILMN), a world leader in genomics, announce the launch of bioMérieux EpiSeq™, an innovative next-generation sequencing (NGS) service dedicated to the epidemiological monitoring and control of healthcare-associated infections.

bioMérieux is a proud supporter of Get Smart about Antibiotics Week

19 November, 2015

World leader in microbiology launches educational campaign focused on antibiotic resistance

bioMérieux introduces GENE-UP®, a new molecular diagnostic solution for food pathogen detection jointly developed with BioFire

04 November, 2015

New generation PCR system benefits from the combined expertise of bioMérieux, world leader in microbiological food safety control and of BioFire, reputed for its know-how in molecular biology

bioMérieux – Business review for the nine months ended September 30, 2015

22 October, 2015

MARCY L'ETOILE – October 22, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, 2015.

In an extremely favorable business momentum BioFire Diagnostics receives a de novo clearance by the FDA for the FilmArray® Meningitis/Encephalitis panel

12 October, 2015

FilmArray® expanded menu, with a fourth panel, is the largest available on a molecular biology multiplex platform

Second National Forum on Sepsis Coverage on U.S. News & World Report

18 September, 2015

From U.S. News & World Report: Sepsis is responsible for 250,000 deaths a year in the U.S., mostly because treatment isn't given in time.

Pioneering Diagnostics